BioResearch
Anatomic Origin No Longer Basis for Cancer Therapy
Traditional cancer therapies, based on different drug regimens for brain, prostate, or ovarian cancer may soon be replaced with therapies that use drugs deemed to be of highest benefit, based on the tumor's pharmacologic profile rather than anatomic origin. More...28 Apr 2006
In Other News
Singapore Undertakes Major Biomedical Expansion
Oral Bacteria May Cause Preterm Births
Capsaicin Shown to Be Potent Anticancer Agent
Primitive Stem Cells Discovered in Adult Tissue
Light-Activated Anticancer Drug Targeted to DNA
Omega-3 Fatty Acids Found to Suppress Liver Cancer
Lipid Micelles May Replace Viruses for Gene Therapy
Modifying Brain's Immune Response to Kill Tumors
Preclinical Hybrid Imaging Platform
Genes Contributing to Cell Growth Identified
GE Announces New Life Sciences Business
New Review Casts Doubts on Benefits of Omega-3s
Probes Image Molecular Processes in Vivo
Technique to Insure Stable Supply of Flu Drug
Bone Marrow Stromal Cells May Regenerate Brain Tissue
Chemists Synthesize a Common Antibiotic
RNAi Engineering May Prevent Mad Cow
Protein in Snake Venom Stops Bleeding
Web Portal Offers Fast Search of Trial Data
Botanical Extract Yields Cancer Drug
Human Quadrupeds Pose Mystery
Telomerase Therapy Stimulates Blood-Vessel Growth
Artificial Heart Tissue Developed in Vitro
BioResearch brings the latest research news on the genome, proteome, metabolome, on drug discovery, and therapeutics. Biotech researchers, lab administrators, technologists, drug manufacturers, and suppliers can find the latest research news and information related to their fields of endeavor here.







